Candriam SCA’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,122,598
Closed -$33.3M 749
2023
Q4
$33.3M Buy
1,122,598
+10
+0% +$297 0.23% 99
2023
Q3
$17.8M Buy
1,122,588
+130,006
+13% +$2.06M 0.13% 159
2023
Q2
$18.7M Sell
992,582
-1,396,714
-58% -$26.4M 0.14% 169
2023
Q1
$8.44M Sell
2,389,296
-300,000
-11% -$1.06M 0.06% 278
2022
Q4
$13.3M Sell
2,689,296
-165,339
-6% -$820K 0.09% 218
2022
Q3
$13.6M Buy
2,854,635
+1,798,196
+170% +$8.6M 0.1% 213
2022
Q2
$4.75M Buy
+1,056,439
New +$4.75M 0.04% 329
2021
Q4
Sell
-2,562,935
Closed -$14.5M 884
2021
Q3
$14.5M Buy
2,562,935
+101,476
+4% +$575K 0.1% 220
2021
Q2
$16.2M Buy
+2,461,459
New +$16.2M 0.11% 218
2019
Q3
Sell
-579,210
Closed -$1.25M 821
2019
Q2
$1.25M Sell
579,210
-575,511
-50% -$1.24M 0.02% 609
2019
Q1
$3.13M Buy
1,154,721
+133,582
+13% +$362K 0.04% 409
2018
Q4
$4.9M Buy
1,021,139
+68,639
+7% +$329K 0.08% 285
2018
Q3
$9.02M Buy
952,500
+258,500
+37% +$2.45M 0.12% 205
2018
Q2
$6.75M Buy
694,000
+100,000
+17% +$973K 0.11% 242
2018
Q1
$6.25M Buy
594,000
+24,000
+4% +$252K 0.11% 243
2017
Q4
$3.65M Hold
570,000
0.06% 330
2017
Q3
$4.36M Hold
570,000
0.08% 291
2017
Q2
$4.05M Buy
+570,000
New +$4.05M 0.08% 307
2016
Q2
Sell
-208,000
Closed -$1.76M 682
2016
Q1
$1.76M Sell
208,000
-30,100
-13% -$255K 0.04% 343
2015
Q4
$3.23M Hold
238,100
0.09% 240
2015
Q3
$2.29M Sell
238,100
-61,900
-21% -$594K 0.06% 317
2015
Q2
$4.31M Sell
300,000
-60,000
-17% -$863K 0.09% 261
2015
Q1
$3.22M Sell
360,000
-125,000
-26% -$1.12M 0.06% 323
2014
Q4
$2.96M Buy
+485,000
New +$2.96M 0.06% 309